3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Prostatic Neoplasms
13
Brain Neoplasms
12
Sarcoma
7
Meningioma
6
Pancreatic Neoplasms
5
Lung Neoplasms
5
Glioma
5
Esophageal Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Glioblastoma
4
Carcinoma, Hepatocellular
4
Breast Neoplasms
4
Solid Tumor, Adult
3
Rhabdomyosarcoma
3
Head and Neck Neoplasms
3
Chondrosarcoma
3
Uterine Cervical Neoplasms
2
Thymus Neoplasms
2
Radiation Injuries
2
Pituitary Neoplasms
2
Pinealoma
2
Osteosarcoma
2
Oligodendroglioma
2
Nerve Sheath Neoplasms
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Liver Neoplasms
2
Hodgkin Disease
2
Gliosarcoma
2
Interventions
Cyclophosphamide
7
pembrolizumab
6
Radiotherapy
6
Cisplatin
6
Sunitinib
5
Carboplatin
5
Paclitaxel
4
Thymectomy
3
130-nm albumin-bound paclitaxel
3
selinexor
2
lenvatinib
2
fludarabine
2
Taxes
2
Robotic Surgical Procedures
2
Ramucirumab
2
Prednisone
2
Pemetrexed
2
Octreotide
2
Nivolumab
2
N,1,4,4-tetramethyl-8-((4-(4-methylpiperazin-1-yl)phenyl)amino)-4,5-dihydro-1H-pyrazolo(4,3-h)quinazoline-3-carboxamide
2
Methylprednisolone
2
Imatinib Mesylate
2
Etoposide
2
Erlotinib Hydrochloride
2
Doxorubicin
2
Chemoradiotherapy
2
Celecoxib
2
zimberelimab
1
vorolanib
1
saracatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Thymoma
×
Proton Therapy
×
Clear all
NCT04822077
2021-03-30
PROTHYM
Swedish Lung Cancer Study Group
Phase NA
Recruiting
40 enrolled